Preset Insider Trade Ideas Penny Stock Buys Insider Trading All Insider Purchases All Insider Sales All Insider Purchases Above 25K Officer Sales Above 25K CEO/CFO Sales Above 25K Insider Purchases Today Insider Purchases Past Week Insider Purchases Past Month Officer Purchases Today Officer Purchases Past Week Officer Purchases Past Month Officer Purchases Past Week Officer Purchases Past Month Insider Sales Today Insider Sales Past Week Insider Sales Past Month Officer Sales Today Officer Sales Past Week
Vivo Opportunity Fund, L.P.'s Net Worth $0
Estimate Recalculated Sep 17, 2024 11:50PM EST
Who is Vivo Opportunity Fund, L.P. Vivo Opportunity Fund, L.P. does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Sierra Oncology, Inc., Crinetics Pharmaceuticals, Inc., ALX ONCOLOGY HOLDINGS INC, Kadmon Holdings, Inc., Bolt Biotherapeutics, Inc., and Terns Pharmaceuticals, Inc..
SEC CIK Vivo Opportunity Fund, L.P.'s CIK is 0001726403
Past Insider Trading and Trends
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Crinetics Pharmaceuticals, Inc. Investor
Updated Mar 11, 2020
Kadmon Holdings, Inc. Investor
Updated Jan 08, 2019
Bolt Biotherapeutics, Inc. Investor
Updated Feb 09, 2021
Terns Pharmaceuticals, Inc. Investor
Updated Feb 09, 2021
Sierra Oncology, Inc. Investor
Updated Jan 31, 2022
ALX ONCOLOGY HOLDINGS INC Investor
Updated Jul 21, 2020